GENERIX GROUP (GENX.PA) Stock Fundamental Analysis

EPA:GENX • FR0010501692

9.7 EUR
+0.04 (+0.41%)
Last: Aug 23, 2022, 07:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to GENX. GENX was compared to 116 industry peers in the Software industry. Both the profitability and financial health of GENX have multiple concerns. GENX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year GENX was profitable.
GENX.PA Yearly Net Income VS EBIT VS OCF VS FCFGENX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 5M 10M

1.2 Ratios

Industry RankSector Rank
ROA 2.84%
ROE 7.39%
ROIC 7.99%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GENX.PA Yearly ROA, ROE, ROICGENX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 2 4 6 8 10

1.3 Margins

Industry RankSector Rank
OM 7.39%
PM (TTM) 4.04%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GENX.PA Yearly Profit, Operating, Gross MarginsGENX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 20 40 60 80

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), GENX is creating some value.
  • The number of shares outstanding for GENX has been increased compared to 1 year ago.
  • GENX has a better debt/assets ratio than last year.
GENX.PA Yearly Shares OutstandingGENX.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M
GENX.PA Yearly Total Debt VS Total AssetsGENX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

2.2 Solvency

  • GENX has an Altman-Z score of 2.75. This is not the best score and indicates that GENX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • GENX has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 2.75
ROIC/WACC1.18
WACC6.77%
GENX.PA Yearly LT Debt VS Equity VS FCFGENX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 10M 20M 30M 40M

2.3 Liquidity

  • A Current Ratio of 0.98 indicates that GENX may have some problems paying its short term obligations.
  • GENX has a Quick Ratio of 0.98. This is a bad value and indicates that GENX is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.98
GENX.PA Yearly Current Assets VS Current LiabilitesGENX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M

3

3. Growth

3.1 Past

  • The earnings per share for GENX have decreased strongly by -33.12% in the last year.
  • Measured over the past years, GENX shows a very strong growth in Earnings Per Share. The EPS has been growing by 42.98% on average per year.
  • GENX shows a small growth in Revenue. In the last year, the Revenue has grown by 5.29%.
  • The Revenue has been growing slightly by 6.05% on average over the past years.
EPS 1Y (TTM)-33.12%
EPS 3Y11.67%
EPS 5Y42.98%
EPS Q2Q%-78.02%
Revenue 1Y (TTM)5.29%
Revenue growth 3Y3.31%
Revenue growth 5Y6.05%
Sales Q2Q%2.07%

3.2 Future

  • GENX is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.42% yearly.
  • The Revenue is expected to grow by 5.01% on average over the next years.
EPS Next Y-28.57%
EPS Next 2Y-4.88%
EPS Next 3Y-4.22%
EPS Next 5Y-3.42%
Revenue Next Year4.41%
Revenue Next 2Y5.53%
Revenue Next 3Y4.84%
Revenue Next 5Y5.01%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
GENX.PA Yearly Revenue VS EstimatesGENX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
GENX.PA Yearly EPS VS EstimatesGENX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15 0.2

0

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 80.83, the valuation of GENX can be described as expensive.
  • Compared to an average S&P500 Price/Earnings ratio of 27.13, GENX is valued quite expensively.
  • Based on the Price/Forward Earnings ratio of 63.40, the valuation of GENX can be described as expensive.
  • GENX is valuated expensively when we compare the Price/Forward Earnings ratio to 28.11, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 80.83
Fwd PE 63.4
GENX.PA Price Earnings VS Forward Price EarningsGENX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.42
GENX.PA Per share dataGENX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • GENX's earnings are expected to decrease with -4.22% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)1.88
EPS Next 2Y-4.88%
EPS Next 3Y-4.22%

0

5. Dividend

5.1 Amount

  • GENX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GENERIX GROUP

EPA:GENX (8/23/2022, 7:00:00 PM)

9.7

+0.04 (+0.41%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap220.19M
Revenue(TTM)84.50M
Net Income(TTM)3.41M
Analysts85.71
Price Target9.69 (-0.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 80.83
Fwd PE 63.4
P/S 2.61
P/FCF N/A
P/OCF N/A
P/B 4.77
P/tB N/A
EV/EBITDA 20.42
EPS(TTM)0.12
EY1.24%
EPS(NY)0.15
Fwd EY1.58%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.72
BVpS2.03
TBVpSN/A
PEG (NY)N/A
PEG (5Y)1.88
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 2.84%
ROE 7.39%
ROCE N/A
ROIC 7.99%
ROICexc N/A
ROICexgc 40.65%
OM 7.39%
PM (TTM) 4.04%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.98
Altman-Z 2.75
F-Score7
WACC6.77%
ROIC/WACC1.18
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.12%
EPS 3Y11.67%
EPS 5Y42.98%
EPS Q2Q%-78.02%
EPS Next Y-28.57%
EPS Next 2Y-4.88%
EPS Next 3Y-4.22%
EPS Next 5Y-3.42%
Revenue 1Y (TTM)5.29%
Revenue growth 3Y3.31%
Revenue growth 5Y6.05%
Sales Q2Q%2.07%
Revenue Next Year4.41%
Revenue Next 2Y5.53%
Revenue Next 3Y4.84%
Revenue Next 5Y5.01%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

GENERIX GROUP / GENX.PA FAQ

Can you provide the ChartMill fundamental rating for GENERIX GROUP?

ChartMill assigns a fundamental rating of 3 / 10 to GENX.PA.


Can you provide the valuation status for GENERIX GROUP?

ChartMill assigns a valuation rating of 0 / 10 to GENERIX GROUP (GENX.PA). This can be considered as Overvalued.


What is the profitability of GENX stock?

GENERIX GROUP (GENX.PA) has a profitability rating of 4 / 10.


What is the valuation of GENERIX GROUP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for GENERIX GROUP (GENX.PA) is 80.83 and the Price/Book (PB) ratio is 4.77.